Home/Filings/4/0001062993-24-008251
4//SEC Filing

Seven One Eight Three Four Irrevocable Trust 4

Accession 0001062993-24-008251

CIK 0001453687other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 4:20 PM ET

Size

22.4 KB

Accession

0001062993-24-008251

Insider Transaction Report

Form 4
Period: 2024-04-08
Transactions
  • Conversion

    Series A Non-Voting Convertible Preferred Stock

    2024-04-0887,802.95101,953.444 total(indirect: By Trust)
    Common Stock (2,926,764 underlying)
  • Conversion

    Common Stock

    2024-04-08+491,853506,377 total(indirect: By Spouse)
  • Conversion

    Common Stock

    2024-04-08+2,926,7643,036,887 total(indirect: By Trust)
  • Conversion

    Series A Non-Voting Convertible Preferred Stock

    2024-04-0814,755.6090 total(indirect: By Spouse)
    Common Stock (491,853 underlying)
Transactions
  • Conversion

    Series A Non-Voting Convertible Preferred Stock

    2024-04-0887,802.95101,953.444 total(indirect: By Trust)
    Common Stock (2,926,764 underlying)
  • Conversion

    Common Stock

    2024-04-08+2,926,7643,036,887 total(indirect: By Trust)
  • Conversion

    Common Stock

    2024-04-08+491,853506,377 total(indirect: By Spouse)
  • Conversion

    Series A Non-Voting Convertible Preferred Stock

    2024-04-0814,755.6090 total(indirect: By Spouse)
    Common Stock (491,853 underlying)
Footnotes (2)
  • [F1]Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer ("Series A Preferred Stock") into shares of common stock of the issuer ("Common Stock"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion.
  • [F2]Shares are owned directly by Seven One Eight Three Four Irrevocable Trust (the "Trust"). The reporting person is a trustee and beneficiary of the Trust.

Issuer

Cartesian Therapeutics, Inc.

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0002000959

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:20 PM ET
Size
22.4 KB